Skip to main content Accessibility help
×
Home

Cerebrovascular disease: a clinical approach

  • Graeme J Hankey (a1)

Abstract

  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.

Copyright

Corresponding author

Graeme J Hankey, Stroke Unit, Department of Neurology, Royal Perth Hospital, Wellington Street, Perth, Western Australia 6001, Australia.

References

Hide All
1National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637–76.
2Hankey, GJ, Warlow, CP. Transient ischaemic attacks of the brain and eye. London: Baillière Tindall, WB Saunders, 1994.
3Dennis, MS, Bamford, JM, Sandercock, PAG, Molyneux, A, Warlow, CP. Computerised tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke? J Neurol 1990; 237: 257–61.
4Hatano, S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541–53.
5Bamford, J, Sandercock, P, Dennis, M, Burn, J, Warlow, C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53: 1622.
6Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG: Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke study, 1989–1990. Med J Aust 1993; 158: 8589.
7Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. A comparison of risk factors and prognosis for transient ischaemic attacks and minor ischaemic strokes. The Oxfordshire Community Stroke Project. Stroke 1989; 20: 1494–99.
8Dennis, M, Bamford, J, Sandercock, P, Warlow, C. Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990; 21: 848–53.
9Hankey, GJ, Slattery, JM, Warlow, CP. The prognosis of hospital-referred transient ischaemic attacks. J Neural Neurosurg Psychiatry 1991; 54: 793802.
10Dennis, MS, Burn, JPS, Sandercock, PAG, Bamford, JM, Wade, DT, Warlow, CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993; 24: 796800.
11Erkinjuntti, T, Hachinski, VC: Rethinking vascular dementia. Cerebrovasc Dis 1993; 3: 323.
12Secretary of State for Health. The Health of the Nation. London: HMSO, 1991.
13Martin, J, Meltzer, H, Elliot, D. For the Office of population censuses and surveys: OPCS surveys of disability in Great Britain, Report 1. The prevalence of disability among adults. London: HMSO, 1988.
14Bamford, J, Sandercock, P, Dennis, M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988; 51: 1373–80.
15Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989–1990. Med J Aust 1993; 158: 8084.
16Wade, DT, Langton-Hewer, R, Skilbeck, CE, David, RM. Stroke. A critical approach to diagnosis, treatment and management. London: Chapman & Hall, 1985.
17Bonita, RB, Beaglehole, R. Explaining stroke mortality trends. Lancet 1993; 341: 1510–11.
18Malmgren, R, Bamford, J, Warlow, C, Sandercock, P, Slattery, J. Projecting the number of patients with first-ever strokes and patients newly handicapped by stroke in England and Wales. Br Med J 1989; 298: 656–60.
19Carstairs, V. Stroke: resource consumption and the cost to the community. In: Gillingham, FJ, Mawdsley, C, Williams, AE eds. Stroke proceedings of the ninth international Pfizer symposium. Edinburgh: Churchill Livingstone, 1976: 516–28.
20Isard, PA, Forbes, JF. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis 1992; 2: 4750.
21Hankey, GJ, Warlow, CP. The role of imaging in the management of cerebral and ocular ischaemia. Neuroradiology 1991; 33: 381–90.
22Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. Incidence of transient ischaemic attacks in Oxfordshire, England. Stroke 1989; 20: 333–39.
23Kraaijeveld, CL, van Gijn, J, Schouten, HJA, Staal, A. Interobserver agreement for the diagnosis of transient ischaemic attacks. Stroke 1984; 15: 723–25.
24Kessler, C, Freyberger, HJ, Dittmann, V, Ringelstein, EB. Interrater reliability in the assessment of neurovascular diseases. Cerebrovasc Dis 1991; 1: 4348.
25Dennis, MS, Warlow, CP. Migraine aura without headache: transient ischaemic attack or not? J Neural Neurosurg Psychiatry 1992; 55: 437–40.
26Olesen, J, Friberg, L, Olsen, TK et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993; 116: 187202.
27O'Sullivan, F, Rossor, M, Elston, JS. Amaurosis fugax in young people. Br J Ophthalmol 1992; 76: 660–62.
28Rao, ML, Stefan, H, Bauer, J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 1989; 49: 3339.
29Hodges, JR, Warlow, CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neural Neurosurg Psychiatry 1990; 53 834–43.
30UK-TIA Study Group. Intracranial tumours that mimic transient cerebral ischaemia: lessons from a large multicentre trial. J Neural Neurosurg Psychiatry 1993; 56: 563–66.
31Bogousslavsky, J, Vinuela, F, Barnett, HJM, Drake, CG: Amaurosis fugax as the presenting manifestation of dural arteriovenous malformation. Stroke 1985; 16: 891–93.
32Moster, ML, Johnston, DE, Reinmuth, OM. Chronic subdural haematoma with transient neurological deficits: a review of 15 cases. Ann Neurol 1983; 14: 539–42.
33Twomey, JA, Espir, MLE. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neural Neurosurg Psychiatry 1980; 43: 296304.
34Rother, J, Schreiner, A, Wentz, K-U, Hennerici, M. Hypoglycaemia presenting as basilar artery thrombosis. Stroke 1992; 23: 112–13.
35Longo, DL, Witherspoon, JM. Focal neurological symptoms in hypercalcaemia. Neurology 1980; 30: 200201.
36Ruby, RJ, Burton, JR. Acute reversible hemiparesis and hyponatraemia. Lancet 1977; 1: 1212.
37Dawson, DM, Hallett, M, Millender, LH. Entrapment neuropathies, second edition. Boston: Little, Brown & Co, 1990: 333.
38Blau, JN, Wiles, CM, Solomon, FS. Unilateral somatic symptoms due to hyperventilation. Br Med J 1983; 286: 1108.
39Bogousslavsky, J, Regli, F. Vertebrobasilar transient ischaemic attacks in internal carotid artery occlusion or tight stenosis. Arch Neurol 1985; 42: 6468.
40Sandercock, PAG, Allen, CMC, Corston, RN, Harrison, MJG, Warlow, CP. Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J 1985; 291: 1675–77.
41Poungvarin, N, Viriyavejakul, A, Komontri, C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. Br Med J 1991; 302: 1565–67.
42Donnan, GA. Investigation of patients with stroke and transient ischaemic attacks. Lancet 1992; 339: 473–77.
43Dennis, MS, Bamford, JM, Molyneux, AJ, Warlow, CP. Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med M 1987;295: 379–81.
44Edelman, RR, Warach, S. Magnetic resonance imaging (second of two parts). N Engl J Med 1993; 328: 785–91.
45Hopkins, A, Menken, M, DeFriese, GH, Feldman, RG. Differences in strategies for the diagnosis and treatment of neurologic disease among British and American neurologists. Arch Neurol 1989; 46: 1142–48.
46UK-TIA Study Group. Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA Aspirin Trial. Br Med J 1983; 286: 514–17.
47Hankey, GJ, Warlow, CP. Cost-effective investigation of patients with suspected transient ischaemic attacks. J Neural Neurosurg Psychiatry 1992; 55: 171–76.
48Caplan, LR. Intracerebral haemorrhage. Lancet 1992; 339: 656–58.
49van Gijn, J. Subarachnoid haemorrhage. Lancet 1992; 339: 653–55.
50Donnan, GA, Bladin, PF, Berkovic, SF, Longley, WA, Saling, MM. The stroke syndrome of striatocapsular infarction. Brain 1991; 114: 5170.
51Hankey, GJ, Warlow, CP. Lacunar transient ischaemic attacks: a clinically useful concept? Lancet 1991; 337: 335–38.
52Hommel, M, Besson, G, Le Bas, JF et al. Prospective study of lacunar infarction using magnetic resonance imaging. Stroke 1990; 21: 546–54.
53Waterston, JA, Brown, MM, Butler, P, Swash, M. Small deep cerebral infarcts associated with occlusive internal carotid artery disease. Arch Neurol 1990; 47: 953–57.
54Hankey, GJ, Khangure, MS, Stewart-Wynne, EG. Detection of basilar artery thrombosis by computed tomography. Clin Radiol 1988; 39: 140–43.
55Virapongse, C, Cazenave, C, Quisling, R, Sarwar, M, Hunter, S. The empty delta sign. Frequency and significance in 76 cases of dural sinus thrombosis. Radiology 1987; 162: 779–85.
56Woo, J, Lam, CWK, Kay, R, Wong, HY, Teoh, R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407–11.
57Sandercock, PAG, Warlow, CP, Jones, LN, Starkey, IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. Br Med J 1989; 298: 7580.
58Hughes, GRV: The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341–44.
59Greaves, M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry 1993; 56: 433–39.
60European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991; 337: 1235–43.
61North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–53.
62Hankey, GJ, Warlow, CP. Symptomatic carotid ischaemic events: safest and most cost-effective way of selecting patients for angiography, before carotid endarterectomy. Br Med J 1990; 300: 1485–91.
63Hu, H-H, Sheng, W-Y, Yen, M-Y, Lai, S-T, Teng, MM-H: Colour Doppler imaging of orbital arteries for detection of carotid occlusive disease. Stroke 1993;24: 1196–203.
64Humphrey, P, Sandercock, P, Slattery, J. A simple method to improve the accuracy of non-invasive ultrasound in selecting TIA patients for cerebral angiography. J Neurol Neurosurg Psychiatry 1990; 53: 966–71.
65Lewis, BD, James, EM, Welch, TJ. Current applications of Duplex and color Doppler ultrasound imaging: carotid and peripheral vascular system. Mayo Clin Proc 1989; 64: 1147–57.
66Carroll, BA: Carotid sonography. Radiology 1991; 178: 303–13.
67Steinke, W, Hennerici, M, Rautenberg, W, Mohr, JP. Symptomatic and asymptomatic high-grade stenoses in Doppler colour-flow imaging. Neurology 1992; 42: 131–38.
68Hankey, GJ, Warlow, CP, Sellar, RJ. Cerebral angiographie risk in mild cerebrovascular disease. Stroke 1990; 21: 209–22.
69Hankey, GJ, Warlow, CP, Molyneux, AJ. Complications of cerebral angiography for patients with mild carotid territory ischaemia being considered for carotid endarterectomy. J Neurol Neurosurg Psychiatry 1990; 53: 542–48.
70Davies, KN, Humphrey, PR. Complications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound. J Neurol Neurosurg Psychiatry 1993; 56: 967–72.
71Hart, RG. Cardiogenic embolism to the brain. Lancet 1992; 339: 589–94.
72DeRook, FA, Comess, KA, Albers, GW. Popp, RL. Transoesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992; 117: 922–32.
73Rose, G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.
74Shaper, AG, Phillips, AN, Pocock, SJ, Walker, M, Macfarlane, PW. Risk factors for stroke in middle aged British men. Br Med J 1991; 302: 1111–15.
75Donnan, GA, You, R, Thrift, A, McNeil, JJ. Smoking as a risk factor for stroke. Cerebrovasc Dis 1993; 3: 129–38.
76Alderman, MH. Blood pressure management: individualised treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119: 329–35.
77MacMahon, S, Peto, R, Cutler, J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74.
78Collins, R, Peto, R, MacMahon, S et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38.
79Hankey, GJ, Slattery, JM, Warlow, CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neural Neurosurg Psychiatry 1992; 55: 640–52.
80Antiplatelet Trialists Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81106.
81The SALT Collaborative Group (Britton, M, Elwin, C-E, Helmers, C et al. ) Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemie events. Lancet 1991; 338: 1345–49.
82The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 versus 283 mg a day) in patients after a transient ischaemic attack or minor ischaemic stroke. N Engl J Med 1991; 325: 1261–66.
83European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255–62.
84Petersen, P, Boysen, G, Godfredsen, J, Andersen, E, Andersen, B. Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1988; 1: 175–79.
85The Stroke Prevention in Atrial Fibrillation Study Group. The stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527–39.
86The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505–11.
87Connolly, SJ, Laupacis, A, Gent, M, Roberts, RS, Cairns, JA, Joyner, C, for the CAFA Study Coinvestigators. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991; 18: 349–55.
88Ezekowitz, MD, Bridgers, SL, James, KE et al. for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation (SPINAF) Investigators. Warfarin in the prevention of stroke associated with atrial fibrillation. N Engl J Med 1992; 327: 1406–f12.
89Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687–91.
90Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: clinical features of patients at risk. Ann Intern Med 1992; 116: 15.
91Clagett, GP, Youkey, JR, Brigham, RA et al. Asymptomatic cervical bruit and abnormal ocular plethysmography: a prospective study comparing two approaches to management. Surgery 1984; 96: 823–30.
92The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991; 22: 1229–35.
93Mayo Asymptomatic Carotid Endarterectomy Group. Results of a randomised controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc 1992; 67: 513–18.
94Hobson, RW II, Weiss, DG, Fields WS et al. and the Veterans Affairs Cooperative Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993; 328: 221–27.
95Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomised prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke 1989; 20: 844–49.
96EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischaemic stroke. N Engl J Med 1985; 313: 1191–200.
97Brown, MM, Butler, P, Gibbs, J, Swash, M, Waterston, J. Feasibility of percutaneous transluminal angioplasty for carotid artery stenosis. J Neurol Neurosurg Psychiatry 1990; 53: 238–43.
98Sandercock, P, Willems, H. Medical treatment of acute ischaemic stroke. Lancet 1992; 339: 537–39.
99Wardlaw, JM, Warlow, CP. Thrombolysis in acute ischaemic stroke. Does it work? Stroke 1992; 23: 1826–39.
100Sandercock, PAG, van den Belt, AGM, Lindley, RI, Slattery, J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 1993; 56: 1725.
101Scatton, B, Carter, C, Benavides, J, Giroux, C. N-Methyl-D-Aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischaemic brain injury. Cerebrovasc Dis 1991; 1: 121–35.
102Czlonkowska, A, Mendel, T, Baranska-Gieruszcak, M. Naloxone in acute ischaemic stroke: double blind controlled study. J Neurol 1990; 237: 153.
103Schmidley, JW. Free radicals in central nervous system ischaemia. Stroke 1990; 21: 1086–90.
104Argentino, C, Sacchetti, ML, Toni, D et al. GM1 Ganglioside therapy in acute ischaemic stroke. Stroke 1989; 20: 1143–49.
105Goldstein, LB, Davis, JN. Restorative neurology. Drugs and recovery following stroke. Stroke 1990; 21: 1636–39.
106Pickard, JD, Murray, GD, Illingworth, R et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British aneurysm nimodipine trial. Br Med J 1989; 298: 636–42.

Related content

Powered by UNSILO

Cerebrovascular disease: a clinical approach

  • Graeme J Hankey (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.